- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT02709317
Preventing Risky Drinking in Veterans Treated With Prescription Opioids
9 december 2021 uppdaterad av: University of Pennsylvania
Veterans who are taking prescription opioids for chronic pain and are engaging in risky drinking are at heightened risk for drug interactions, including overdose and other negative effects, particularly if they are also using benzodiazepines.
The investigators propose to test a prevention intervention, designed to reduce rates of risky drinking in veterans receiving prescription opioids to treat their chronic pain.
This adaptive, patient-centered intervention provides clinical assessment, brief intervention, monitoring, and extended prevention services delivered through a combination of clinical visits, telephone calls, and text messages.
The investigators propose to conduct a study in which veterans (N=300) who are on daily doses of prescription opioids will be randomized to receive 12 months of an adaptive prevention intervention (PI) or to standard care (SC), which consists of a Brief Intervention (BI) with 2 follow-up contacts.
Potential participants will be veterans at the Philadelphia VA, and surrounding areas, or the Pittsburgh VA who, based on pharmacy records, are using opioids daily to treat chronic pain.
An initial evaluation will identify individuals who also engage in risky alcohol use based on NIAAA-recommended guidelines and meet other inclusion criteria to be enrolled in the study.
The evaluation will also identify the use of other medications (e.g., benzodiazepines) that could interact negatively with opioid use.
For veterans randomized to the PI condition, a BI is first provided to reduce alcohol to non-hazardous levels and the effects are monitored for one month.
Veterans who reduce alcohol use to non-hazardous levels during this one-month period continue in a monitoring track, consisting of tailored text messages and brief monthly telephone contacts.
Veterans who continue to drink at risky levels are instead placed in a track that provides tailored text messages and more frequent telephone calls.
In addition to monitoring, these calls provide further prevention/BI services to help the veteran reduce alcohol use to non-hazardous levels.
Key components of these services are motivational enhancement and development of more effective ways to cope with stress and other triggers for risky alcohol use.
All participants will be followed up at 3, 6, 9, 12 and 18 months after baseline.
The primary outcome at each follow-up point will be a dichotomous measure of any risky drinking since the prior follow-up (yes/no).
Secondary outcomes will include self-reported frequency of heavy drinking, biological measures of alcohol use, other drug use as determined by urine toxicology tests, opioid overdoses, and ratings of depression and pain.
Repeated measures analyses will compare the PI and SC conditions on primary and secondary outcomes assessed across an 18-month follow-up.
Analyses will also test hypothesized moderation and mediation effects.
Studieöversikt
Status
Avslutad
Betingelser
Intervention / Behandling
Studietyp
Interventionell
Inskrivning (Faktisk)
108
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Förenta staterna, 19104
- University of Pennsylvania
-
Philadelphia, Pennsylvania, Förenta staterna, 19104
- Philadelphia VA Medical Center
-
Pittsburgh, Pennsylvania, Förenta staterna, 15261
- VA Pittsburgh Health System
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
18 år till 88 år (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
- currently be receiving daily treatment with a prescription opioid for chronic pain;
- be 18 years or older;
- have a cell phone capable of receiving text messages;
- and be willing to be in a study where they might receive text messages.
Exclusion Criteria:
- meet DSM-V criteria for a moderate to severe alcohol or drug disorder (with the exception of nicotine abuse/dependence);
- have a current psychotic disorder severe enough to require inpatient treatment;
- are participating in substance abuse treatment at the VA or elsewhere (with exception of screening and brief intervention at the VA).
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Aktiv komparator: Standard Care
In this arm, veterans receive the care that they would receive had they not enrolled in the research.
No one will receive less than standard care.
|
|
Experimentell: Prevention Intervention
An adaptive monitoring intervention, delivered through text messages and brief telephone calls, that can provide extended prevention services for veterans engaging in risky alcohol use.
After a veteran receives a BI for risky drinking, we will monitor alcohol use for 4 weeks.
Veterans who reduce alcohol use to safe levels will be placed in a monitoring track, which consists of tailored text messages and brief monthly telephone contacts.
Conversely, veterans who continue to use alcohol at hazardous levels will be placed in a track that provides tailored text messages and more frequent telephone calls.
These calls provide further prevention/intervention services to help the veteran reduce alcohol use.
These services address motivational issues and identify more effective ways to cope with stress and other factors that trigger unsafe alcohol use.
Information on the veteran's progress is used to guide the content of subsequent text messages and prevention interventions.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Rates of Risky Drinking, Week 13
Tidsram: weeks 1 - 13
|
The primary outcome measure will be rates of the presence of any risky drinking in each week (i.e., more than 4 drinks per drinking day) as reported on the Time Line Follow Back.
|
weeks 1 - 13
|
Rates of Risky Drinking, Week 26
Tidsram: weeks 14 - 26
|
Rates of the presence of any risky drinking in each week (14 - 26)
|
weeks 14 - 26
|
Rates of Risky Drinking, Week 39
Tidsram: weeks 27 - 39
|
Rates of the presence of any risky drinking in each week (27 - 39)
|
weeks 27 - 39
|
Rates of Risky Drinking, Week 52
Tidsram: weeks 40 - 52
|
Rates of the presence of any risky drinking in each week (40 - 52)
|
weeks 40 - 52
|
Rates of Risky Drinking, Week 78
Tidsram: weeks 53 - 78
|
Rates of the presence of any risky drinking in each week (53 - 78)
|
weeks 53 - 78
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Samarbetspartners
Utredare
- Huvudutredare: James R McKay, PhD, University of Pennsylvania
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Faktisk)
1 april 2014
Primärt slutförande (Faktisk)
30 september 2020
Avslutad studie (Faktisk)
30 september 2020
Studieregistreringsdatum
Först inskickad
28 januari 2016
Först inskickad som uppfyllde QC-kriterierna
10 mars 2016
Första postat (Uppskatta)
16 mars 2016
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
2 mars 2022
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
9 december 2021
Senast verifierad
1 december 2021
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 818671
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Kort intervention
-
University Hospital, AkershusUniversity of OsloRekryteringSkadlig användning av hypnotiskNorge
-
University Hospital, BonnGerman Federal Ministry of Education and ResearchOkänd
-
University of TulsaAvslutadSjälvmord, försökFörenta staterna
-
Queen's University, BelfastBelfast Health and Social Care Trust; South Eastern Health and Social Care...RekryteringST Elevation hjärtinfarktStorbritannien
-
NYU Langone HealthIndragenInflammatorisk tarmsjukdomFörenta staterna
-
Virginia Commonwealth UniversityCenters for Disease Control and PreventionHar inte rekryterat ännu
-
University of MichiganNational Institute on Drug Abuse (NIDA)AvslutadDrogmissbrukFörenta staterna
-
University of North Carolina, Chapel HillNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Johns Hopkins... och andra samarbetspartnersHar inte rekryterat ännuHIV-förebyggande | Ohälsosam alkoholanvändningVietnam
-
RANDNational Institute on Alcohol Abuse and Alcoholism (NIAAA)AvslutadAlkoholmissbrukFörenta staterna
-
University of MiamiAB InBev FoundationAvslutad